Zhejiang Huahai and Tianjin Pharma to Form US-Aimed Partnership

Zhejiang Huahai Pharma and Tianjin Pharma Group signed a framework agreement to form a partnership that will develop chemical raw material preparations, diagnostic reagents and other products for the US market. Because the partnership process is at a very early stage, no further details are available, except that the partnership will last for ten years, starting from the date a final agreement is signed. More details.... Stock Symbol: (SHA: 600521) Share this with colleagues: // //  
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.